D. Ukena (Bremen, Germany), L. Bjermer (Lund, Sweden)
Suplatast tosilate decreases goblet cell metaplasia in patients with asthma
M. Hoshino, T. Nakagawa, T. Miyazawa (Kawasaki, Japan)
|  |
Phase 2b study of the novel vaccine Amb a 1 immunostimulatory DNA conjugate AIC in ragweed allergic adults
A. S. Nyak, W. Busse, P. Korenblat, G. Gross, D. Levitt (Normal, Madison, St. Louis, Dallas, Berkeley, United States Of America)
| |
Clinical efficiency of sublingual and subcutaneous allergenspecific immunotherapy with household dust mite allergen in patients with persistent allergic rhinitis
E. M. Ditiatkovskaya, I. A. Rodkina, V. E. Makarenko, J. V. Bendetskaya, V. A. Ditiatkovsky (Dnipropetrovsk, Ukraine)
| |
Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study
N. Bergmann, M. Foerster, A. Reissig, C. Kroegel (Jena, Germany)
| |
Early BCG-vaccination may result in suppression of in-vitro TH2-cytokine response at the age of 4 and 18 months in high-risk newborns from non-allergic mothers
T. J. Steenhuis, W. Kuis, H. van der Laag, N. Bloksma, W. M. C. van Aalderen, F. P. Nijkamp, H. van Loveren, G. T. Rijkers, M. O. Hoekstra (Utrecht, Amsterdam, Bilthoven, Netherlands)
| |
Sublingual monomeric allergoid immunotherapy improves airway inflammation, airway hyperresponsiveness and clinical symptoms in allergic rhinitis and asthma
F. Romano, M. I. Scarlato, A. Mancuso, G. Bruni (Cosenza, Italy)
| |
Evaluation of six-year allergen immunotherapy in allergic rhinitis and allergic asthma
R. Farid, S. Miri, R. Ghasemi, F. Jabbari, L. Farid, H. Rafaat Panah (Mashhad, Tehran, Islamic Republic Of Iran; New Jersey, United States Of America)
| |
Beclometasone diproprionate prevents the allergen-induced urinary LTE4 early increase and the following late asthmatic response
M. L. E. Bartoli, F. L. Dente, L. Bancalari, E. Bacci, S. Cianchetti, A. Di Franco, B. Vagaggini, P. Paggiaro (Pisa, Italy)
| |
Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough
K. Nobata, M. Fujimura, M. Abo, S. Furusyou, J. Hara, Y. Ohkura, S. Nakao (Kanazawa, Japan)
| |
Montelukast and budesonide therapy of asthmatic patients suffering from chronic cough
K. Kowal, S. Zukowski, L. M. DuBuske, A. Bodzenta-Lukaszyk (Bialystok, Poland; Gardner, United States Of America)
| |
Add-on omalizumab therapy for patients with severe persistent allergic (IgE-mediated) asthma: identifying which patients to treat and which patients respond
S. Holgate, H. Fox, G. Ayre, M. Blogg (Southampton, Horsham, United Kingdom)
| |
Adding omalizumab to high-dose ICS and LABA significantly improves quality of life in patients with severe persistent allergic asthma
K. M. Beeh, R. Pereno, H. Chen, P. Jimenez (Wiesbaden, Germany; Horsham, United Kingdom; East Hanover, United States Of America)
| |
Simple reaction time after administration of anthihistaminics
P. Rapiejko, A. Lipiec, S. Bialek, A. Wojdas, D. Jurkiewicz (Warsaw, Poland)
| |
Antitussive and antiinflammatory effect of montelukast in patients with cough variant asthma
M. Takemura, A. Niimi, T. Ueda, H. Matsuoka, M. Yamaguchi, M. Jin-nai, H. Matsumoto, M. Mishima (Osaka, Kyoto, Japan)
| |
Severe asthma exacerbations with eosinophilic bronchitis: a randomized controlled comparison of the anti-inflammatory effects of deflazacort vs. prednisone
L. J. Marques, D. A. P. Hansen, C. C. Rocha, C. T. Zimmermann, P. Moritz, S. C. Ferreira, M. M. M. Pizzichini, E. Pizzichini (Florianopolis, Brazil)
| |
Cost effectiveness of omalizumab in Swedish asthma patients
S. Dewilde, P. Dale, F. Turk (Bussels, Belgium; London, United Kingdom; Basel, Switzerland)
| |
Additional anti-inflammatory effects of inhaled budesonide/formoterol over inhaled budesonide in subjects with atopic asthma
T. M. O‘Connor, M. M. Kelly, R. Leigh, J. Otis, G. M. Gauvreau, J. Gauldie, P. M. O‘Byrne (Cork, Ireland; Calgary, Hamilton, Canada)
| |
Specific allergen immunotherapy of asthma combined with allergic rhinitis
D. I. Zabolotniy, I. V. Gogunskaya (Kiev, Ukraine)
| |
Comparitive efficiency of different approaches to basic therapy of bronchial asthma of moderate form
I. A. Rodkina, E. M. Ditiatkovskaya, O. V. Koretskaya, L. V. Gribanova, V. A. Ditiatkovsky (Dnipropetrovsk, Ukraine)
| |
Treatment of acute asthma in the emergency department
M. D. S. L. Cardoso, M. L. V. D Souza, A. L. Boechat, M. A. P. Lima (Manaus, Brazil)
| |